Compare FAST & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FAST | EW |
|---|---|---|
| Founded | 1967 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.2B | 49.5B |
| IPO Year | N/A | 2000 |
| Metric | FAST | EW |
|---|---|---|
| Price | $43.26 | $81.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 21 |
| Target Price | $46.13 | ★ $96.79 |
| AVG Volume (30 Days) | ★ 9.6M | 3.7M |
| Earning Date | 01-20-2026 | 02-10-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | ★ 9.00 | N/A |
| EPS | 1.09 | ★ 2.33 |
| Revenue | ★ $8,200,500,000.00 | $5,883,800,000.00 |
| Revenue This Year | $11.64 | $14.29 |
| Revenue Next Year | $8.29 | $9.73 |
| P/E Ratio | $39.78 | ★ $35.59 |
| Revenue Growth | 8.67 | ★ 10.60 |
| 52 Week Low | $35.31 | $65.94 |
| 52 Week High | $50.63 | $87.89 |
| Indicator | FAST | EW |
|---|---|---|
| Relative Strength Index (RSI) | 53.66 | 37.63 |
| Support Level | $43.38 | $80.44 |
| Resistance Level | $44.13 | $84.69 |
| Average True Range (ATR) | 1.08 | 1.90 |
| MACD | -0.01 | -0.34 |
| Stochastic Oscillator | 54.69 | 15.42 |
Fastenal began as an industrial retailer, expanding its product portfolio from nuts and bolts to cutting tools, safety equipment, and janitorial supplies. It transitioned into a distributor by building out a dense network of branches close to its business customers. Once a customer becomes large enough, Fastenal installs vending machines and its own personnel on-site. Today, these on-site locations exceed Fastenal's branch count and remain the firm's main focus for expansion. Fastenal acts as a one-stop outsourcing partner for its industrial customers, offering value-added services along with a wide breadth of maintenance, repair, and operations supplies.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.